MENU
+Compare
COLL
Stock ticker: NASDAQ
AS OF
May 14, 04:59 PM (EDT)
Price
$29.05
Change
-$0.75 (-2.52%)
Capitalization
1.24B

COLL Collegium Pharmaceutical Forecast, Technical & Fundamental Analysis

Collegium Pharmaceutical Inc is a specialty pharmaceutical company... Show more

COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for COLL with price predictions
May 13, 2025

COLL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for COLL turned positive on April 24, 2025. Looking at past instances where COLL's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 01, 2025. You may want to consider a long position or call options on COLL as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

COLL moved above its 50-day moving average on May 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COLL advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COLL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COLL broke above its upper Bollinger Band on May 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for COLL entered a downward trend on April 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.365) is normal, around the industry mean (60.596). P/E Ratio (30.171) is within average values for comparable stocks, (88.278). COLL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (2.869) is also within normal values, averaging (19.312).

View a ticker or compare two or three
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

COLL is expected to report earnings to rise 8.05% to $1.61 per share on July 31

Collegium Pharmaceutical COLL Stock Earnings Reports
Q2'25
Est.
$1.61
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.03
The last earnings report on May 08 showed earnings per share of $1.49, missing the estimate of $1.50. With 343.19K shares outstanding, the current market capitalization sits at 1.24B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Technology Center Drive
Phone
+1 781 713-3699
Employees
197
Web
https://www.collegiumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

COLL and Stocks

Correlation & Price change

A.I.dvisor tells us that COLL and AMPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COLL and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+0.81%
AMPH - COLL
31%
Poorly correlated
-1.89%
ALKS - COLL
30%
Poorly correlated
-1.38%
SUPN - COLL
27%
Poorly correlated
+0.39%
ZTS - COLL
27%
Poorly correlated
-0.93%
RDY - COLL
26%
Poorly correlated
+1.22%
More